WILMINGTON – The private biopharmaceutical startup NiKang Therapeutics announced Tuesday that it has signed a licensing agreement for one of its small-molecule therapy drugs in China, marking its second such […]
WILMINGTON – The biopharmaceutical startup NiKang Therapeutics announced Wednesday that it has signed a second clinical trial collaboration with a biopharma firm for its small-molecule therapy drug in about a […]
WILMINGTON – The greater Wilmington area is attracting a burgeoning growth of life science firms, many of which are investigating potential cancer treatments. Incyte Corp. and Prelude Therapeutics are among […]
WILMINGTON – NiKang Therapeutics, a clinical stage biotech startup focused on small molecule cancer treatments, recently closed a $200 million Series C financing round, one of the largest such venture […]
Premier Digital Partners
© 2023 Delaware Business Times
